Zhang, P., Zhang, P., Xie, D., Xie, D., Li, Q., & Li, Q. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A.
Citace podle Chicago (17th ed.)Zhang, Peng-Fei, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, a Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
Citace podle MLA (9th ed.)Zhang, Peng-Fei, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..